Treatment patterns among patients with diabetes on metformin and sulfonylurea combination therapy

被引：0
|
作者：
Pietri, G
Yin, D
Lyu, R
机构：
[1] Rutgers State Univ, Piscataway, NJ USA
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62963-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：361 / 361
页数：1
相关论文
共 50 条
  • [1] Liraglutide in Combination with Metformin or Sulfonylurea for the Treatment of Type 2 Diabetes in Adult Patients
    Udiawar, Maneesh V.
    Bain, Stephen C.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2012, 4 : 251 - 261
  • [2] RATIONALE BEHIND THE COMBINATION OF SULFONYLUREA AND METFORMIN IN DIABETES MELLITUS
    Ingle, P. V.
    Talele, G. S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (07): : 1 - 5
  • [3] Quick release bromocriptine (Cycloset™) improves glycaemic control in patients with diabetes failing metformin/sulfonylurea combination therapy
    Scranton, R. E.
    Farwell, W.
    Ezrokhi, M.
    Gaziano, J. M.
    Cincotta, A. H.
    [J]. DIABETOLOGIA, 2008, 51 : S372 - S373
  • [4] Combination therapy with pioglitazone and sulfonylurea in patients with type 2 diabetes
    Schneider, R
    Egan, J
    Houser, V
    [J]. DIABETES, 1999, 48 : A106 - A106
  • [5] Treatment Intensification after Early Failure of Metformin or Sulfonylurea among VA Patients With Type 2 Diabetes
    Wang, Li
    Wei, Wenhui
    Dalal, Mehul
    Baser, Onur
    [J]. DIABETES, 2013, 62 : A329 - A330
  • [6] Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes
    Comaschi, M.
    Demlcheli, A.
    Di Pietro, C.
    Bellatreccia, A.
    Mariz, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (04) : 387 - 398
  • [7] Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
    Khan, Muhammad Shahzeb
    Solomo, Nicole
    DeVore, Adam D.
    Sharma, Abhinav
    Felke, G. Michael
    Hernandez, Adrian F.
    Heidenreich, Paul A.
    Matsouaka, Roland A.
    Green, Jennifer B.
    Butler, Javed
    Yancy, Clyde W.
    Peterson, Pamela N.
    Fonarow, Gregg C.
    Greene, Stephen J.
    [J]. JACC-HEART FAILURE, 2022, 10 (03) : 198 - 210
  • [8] Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes Influence of prior antidiabetic drug regimen
    Rendell, MS
    Glazer, NB
    Ye, Z
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (04) : 211 - 217
  • [9] Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
    Gordon, Jason P.
    Evans, Marc
    Puelles, Jorge
    McEwan, Philip C.
    [J]. DIABETES THERAPY, 2015, 6 (04) : 495 - 507
  • [10] Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea
    Aronson, Ronnie
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1535 - 1539
12345